Beyond Thinking
Welcome to Beyond Blue’s Thought Leadership Hub, where we highlight complex concepts with clarity and showcase our commitment to delivering excellence with ease. Explore our insights, discover innovative perspectives and join us on a journey to navigate the intricate with confidence.
5 Reasons Obesity is Rewriting the Demand Forecasting Playbook
Author: Stephanie Armstrong, Associate Director, Beyond Blue's CVRM team Forecasting demand is never easy. Teams are often required to make major portfolio, investment, and launch decisions years before a therapy reaches the market, in a landscape that may look very...
5 Tips to Get Pharma Market Research Right in the UAE & KSA: Before you even begin
Author: Rhona Chipanga, Research Executive, Beyond Blue There's a lot of opportunity in pharma research across the Gulf, but it only pays off if you understand how these markets actually work. Here are five things you might want to look out for if you are looking at...
The Power of Earlier: Transforming Alzheimer’s care
Authors: Nikita Shah & Nikita Walker, Beyond Blue Historically, Alzheimer's disease has been diagnosed once cognitive symptoms become noticeable and begin affecting daily life. By that stage, the underlying pathology of the disease may have been developing for...
The Most Dangerous Forecast is the One No One Challenges
Author: Sam Hope, CEO, Beyond Blue Demand forecasts have a habit of taking on a life of their own. A peak-share estimate, an uptake curve, a projected patient number – once it is written on a slide, it can start to feel more solid than it really is. Teams debate...
Defining the Behavior You Want to Change
Author: Rhona Auckland, Associate Director, Beyond Behavior, Beyond Blue Picture the scene, you’ve set clear strategic objectives, your market research partner has built in a behavioral science component, something like COM-B or EAST or the Health Belief Model. So,...
ASCO 2026: Key market shifts and considerations
Every year, ASCO stands as a defining moment in oncology research, and the 2026 meeting was no different. Our team has distilled the conference’s most significant market shifts and strategic imperatives, cutting through the volume to focus on what truly matters. Below...
Where’s the “L” in CVRM?
The move towards a holistic approach is advancing at pace The increasing recognition of biological and clinical interconnection between cardiovascular, renal, and metabolic (CVRM) diseases is clear to see. A shift away from siloed, stepwise treatment approaches...
Designing Patient Research for Real Lives (vs. Ideal Scenarios)
Patients don’t behave the way they used to. They’re not just turning up for appointments and following instructions. They’re researching symptoms at 2 am, sense-checking decisions in niche patient forums, and watching other patients talk about their experiences on...
BHBIA 2026: All change, please, all change
Summary: Research isn’t being transformed by tools alone; there’s a broader behavioral shift in where value sits and what clients need from insight partners. Pharma insights teams are building their own insight ecosystems: agency value increasingly comes from...
